Ramipril
Is It Right for You?
A complete guide to Ramipril — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Ramipril?
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used in the treatment of hypertension, heart failure, and for the prevention of cardiovascular events in high-risk patients. It is one of the most widely prescribed cardiovascular medications in the UK and is a cornerstone of management for patients with hypertension, left ventricular dysfunction following myocardial infarction, diabetic nephropathy, and established cardiovascular disease.
Available as capsules (1.25 mg, 2.5 mg, 5 mg, and 10 mg), ramipril is taken once daily and is suitable for adults. It is included on the WHO List of Essential Medicines and features prominently in NICE guidelines for the treatment of hypertension and heart failure.
Ramipril is a prescription-only medication in the UK. A licensed clinician must assess your blood pressure, renal function, serum electrolytes, and medical history before it can be prescribed — which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Ramipril Used For?
Ramipril is licensed for:
first-line treatment, particularly in patients with diabetes, proteinuria, or left ventricular hypertrophy.
following myocardial infarction; also used in symptomatic heart failure with reduced ejection fraction.
initiated within days of an acute MI in patients with clinical signs of heart failure, to reduce mortality.
in patients with established coronary artery disease, peripheral vascular disease, or stroke, and in high-risk diabetic patients, to reduce the risk of MI, stroke, and cardiovascular death.
to slow the progression of renal disease and reduce proteinuria.
High blood pressure rarely causes symptoms until it is very high or has caused end-organ damage. Regular blood pressure monitoring and adherence to antihypertensive treatment are essential even when you feel entirely well — untreated hypertension significantly increases the risk of stroke, heart attack, heart failure, and kidney disease.
How Does Ramipril Work?
Ramipril is a prodrug that is converted in the liver to its active metabolite, ramiprilat. Ramiprilat inhibits angiotensin-converting enzyme (ACE) — the enzyme responsible for converting angiotensin I (an inactive decapeptide) to angiotensin II (a potent vasoconstrictor and aldosterone stimulator) in the renin-angiotensin-aldosterone system (RAAS).
By blocking ACE, ramipril reduces angiotensin II production, causing vasodilation of peripheral arteries and arterioles (lowering blood pressure), reducing aldosterone secretion (decreasing sodium and water retention, reducing volume load), and reducing sympathetic nervous system activation. Ramipril also inhibits the breakdown of bradykinin — a vasodilator peptide normally degraded by ACE — which contributes to its antihypertensive and cardioprotective effects, but is also responsible for the ACE inhibitor cough.
In the kidney, reduced angiotensin II dilates the efferent arteriole (preferentially over the afferent arteriole), reducing intraglomerular pressure and proteinuria — accounting for ramipril's renoprotective effects in diabetic and non-diabetic nephropathy.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Take at the same time each day, with or without food. Consistent timing improves blood pressure control.
Avoid high-potassium foods and salt substitutes (which often contain potassium chloride) in large amounts — ACE inhibitors raise serum potassium by reducing aldosterone, and excessive potassium intake can cause dangerous hyperkalaemia.
Stay well hydrated, particularly in hot weather or during illness — dehydration combined with ramipril increases the risk of acute kidney injury (AKI).
Follow your clinician's sick day guidance — during episodes of vomiting, diarrhoea, or significant illness causing dehydration, ramipril should typically be temporarily withheld until fluid intake is restored.
Allow 4 to 6 weeks at each dose level before assessing the full antihypertensive effect.
Side Effects of Ramipril
Ramipril is generally well tolerated. The most common side effect — a dry, persistent cough — is class-specific to all ACE inhibitors.
- Dry, persistent, non-productive cough (affects 5–20% of patients; due to bradykinin accumulation; a class effect of all ACE inhibitors)
- Dizziness, particularly on standing (first-dose hypotension)
- Headache
- Fatigue
- Nausea
- Raised serum potassium (hyperkalaemia)
- Mild increase in serum creatinine (expected with initiation)
- Angioedema — rapid swelling of the face, lips, tongue, throat, or larynx; life-threatening airway obstruction can occur; seek emergency care immediately; this is a class effect of ACE inhibitors and is a contraindication to all future ACE inhibitor use
- Acute kidney injury — particularly in patients with bilateral renal artery stenosis, hypovolaemia, or concurrent nephrotoxic drugs; characterised by a significant rise in creatinine after initiation
- Severe hyperkalaemia — life-threatening elevated potassium, particularly with concurrent potassium-sparing drugs or in renal impairment
- Severe hypotension — particularly with first dose; risk is highest in volume-depleted patients (on diuretics) or those with heart failure
ACE inhibitor-induced angioedema is potentially life-threatening if it involves the tongue, throat, or larynx. It can occur at any point during treatment — even after years of uneventful use. If swelling of the face, lips, tongue, or throat occurs, discontinue ramipril immediately and call 999. Do not take another ACE inhibitor in future. An angiotensin receptor blocker (ARB) may be a safer alternative, though angioedema has rarely occurred with ARBs also.
Drug Interactions
Always disclose all medications and supplements to your clinician or pharmacist.
Dual blockade of the RAAS is associated with increased rates of hypotension, hyperkalaemia, and renal impairment; generally contraindicated in combination, particularly in diabetic patients.
NSAIDs reduce the antihypertensive effect of ACE inhibitors and increase the risk of acute kidney injury, particularly in elderly, dehydrated, or renally impaired patients. This combination should be avoided where possible.
ACE inhibitors reduce renal lithium clearance, raising lithium levels and increasing toxicity risk. Lithium levels must be monitored closely.
ACE inhibitors may enhance the glucose-lowering effect; blood glucose monitoring is advisable when initiating ramipril in diabetic patients.
Important Warnings
ACE inhibitor-induced angioedema can be life-threatening and can occur at any time during treatment. It is an absolute contraindication to re-prescription of any ACE inhibitor. Patients with a history of idiopathic angioedema or hereditary angioedema should not receive ramipril.
Ramipril is absolutely contraindicated in pregnancy from the second trimester onwards. ACE inhibitors cause fetal renal tubular dysplasia, oligohydramnios, fetal growth restriction, skeletal malformations, and neonatal renal failure. Women of childbearing potential should use effective contraception and switch to a pregnancy-safe antihypertensive immediately on confirmation of pregnancy. If ramipril was used in the first trimester, ultrasound assessment of fetal renal function is recommended.
Ramipril is contraindicated in bilateral renal artery stenosis and must be used with extreme caution in unilateral stenosis of a single functioning kidney, as ACE inhibition can precipitate acute renal failure in these patients.
Renal function and serum potassium must be checked before starting ramipril and 1 to 2 weeks after initiation or any dose increase. A modest rise in creatinine (up to 30%) is expected and acceptable. A larger or rapidly worsening rise should prompt urgent clinical review.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Ramipril FAQs
The dry, persistent cough associated with ACE inhibitors — including ramipril — is caused by the accumulation of bradykinin in the airways. Bradykinin is normally broken down by ACE, but when ACE is inhibited, bradykinin accumulates and stimulates sensory nerve fibres in the respiratory mucosa, triggering an irritating cough. This occurs in 5–20% of patients. It is not dangerous, but can be very bothersome. If the cough is intolerable, switching to an angiotensin receptor blocker (ARB) such as losartan or candesartan provides equivalent blood pressure lowering without causing a cough.
The combination of NSAIDs (such as ibuprofen) and ACE inhibitors is considered potentially harmful and should be avoided where possible, particularly with regular or prolonged use. NSAIDs reduce renal prostaglandin production, impairing renal blood flow autoregulation. In combination with ACE inhibition, this significantly increases the risk of acute kidney injury. For occasional, short-term pain relief, paracetamol is a safer alternative.
First-dose hypotension — a sudden drop in blood pressure — is more likely with the first few doses, particularly if you are already on a diuretic, have heart failure, or are volume-depleted. Take your first dose at bedtime to minimise the impact of any hypotension. Rise slowly from sitting or lying to avoid dizziness. If severe dizziness or fainting occurs, lie down and contact your clinician.
Blood pressure begins to fall within a few hours of the first dose. The full antihypertensive effect at a given dose develops over 3 to 4 weeks. Your clinician will reassess your blood pressure 4 to 6 weeks after starting or changing your dose before deciding whether further adjustment is needed.